Manganese‐based tumor immunotherapy

K Zhang, C Qi, K Cai - Advanced Materials, 2023 - Wiley Online Library
As an essential micronutrient, manganese (Mn) participates in various physiological
processes and plays important roles in host immune system, hematopoiesis, endocrine …

Hybrid nanomaterials for cancer immunotherapy

J Li, W Lu, Y Yang, R Xiang, Y Ling, C Yu… - Advanced …, 2023 - Wiley Online Library
Nano‐immunotherapy has been recognized as a highly promising strategy for cancer
treatment in recent decades, which combines nanotechnology and immunotherapy to …

Metabolic reprogramming mediated PD-L1 depression and hypoxia reversion to reactivate tumor therapy

Z Zhou, Y Liu, W Song, X Jiang, Z Deng… - Journal of Controlled …, 2022 - Elsevier
As a promising cancer treatment, photodynamic therapy (PDT) still achieved limited clinical
success due to the severe hypoxia and programmed death ligand-1 (PD-L1) over-expressed …

Tumor Selective Metabolic Reprogramming as a Prospective PD‐L1 Depression Strategy to Reactivate Immunotherapy

Y Liu, Z Zhou, J Hou, W Xiong, H Kim… - Advanced …, 2022 - Wiley Online Library
Currently, the role of the lysosome, endoplasmic reticulum, or dictyosome in the transcription
and translation of programmed cell death ligand 1 (PD‐L1) is well revealed, but the role and …

Metabolic Intervention Liposome Boosted Lung Cancer Radio‐Immunotherapy via Hypoxia Amelioration and PD‐L1 Restraint

S Wang, Z Zhou, R Hu, M Dong, X Zhou… - Advanced …, 2023 - Wiley Online Library
At present, radiotherapy (RT) still acquires limited success in clinical due to the lessened
DNA damage under hypoxia and acquired immune tolerance owing to the amplified …

Metformin modified chitosan as a multi-functional adjuvant to enhance cisplatin-based tumor chemotherapy efficacy

Z Zhou, Y Liu, X Jiang, C Zheng, W Luo, X Xiang… - International Journal of …, 2023 - Elsevier
Recently, it was newly revealed that the DNA damage induced by cis‑platinum (Cis-Pt)
mediated chemotherapy was significantly impaired by the highly expressed programmed …

[HTML][HTML] Strategies targeting PD-L1 expression and associated opportunities for cancer combination therapy

S Yin, Z Chen, D Chen, D Yan - Theranostics, 2023 - ncbi.nlm.nih.gov
Immunotherapy has achieved great success recently and opened a new avenue for anti-
tumor treatment. Programmed cell death 1/programmed cell death ligand 1 (PD-1/PD-L1) …

Recent progress, perspectives, and issues of engineered PD-L1 regulation nano-system to better cure tumor: A review

Z Zhou, H Wang, J Li, X Jiang, Z Li, J Shen - International Journal of …, 2024 - Elsevier
Currently, immune checkpoint blockade (ICB) therapies that target the programmed cell
death ligand-1 (PD-L1) have been used as revolutionary cancer treatments in the clinic …

Killing three birds with one stone: Multi-stage metabolic regulation mediated by clinically usable berberine liposome to overcome photodynamic immunotherapy …

C Zheng, W Luo, Y Liu, J Chen, H Deng, Z Zhou… - Chemical Engineering …, 2023 - Elsevier
Nowadays, photodynamic therapy (PDT) has become a novel effect modality for cancer
therapy. But, facing the extremely hypoxic tumor microenvironment, the efficacy of PDT is still …

Chitosan biguanide induced mitochondrial inhibition to amplify the efficacy of oxygen-sensitive tumor therapies

Z Zhou, C Zheng, Y Liu, W Luo, H Deng, J Shen - Carbohydrate Polymers, 2022 - Elsevier
At present, the tumor's poor oxygen perfusion and limited tumor drug permeation are the
major bottlenecks that limit the therapeutic effectiveness of the oxygen-sensitive antitumor …